TrialEuropean journal of nuclear medicine and molecular imaging2026

Consolidative therapy for PSMA-avid lesions after 3 cycles of apalutamide plus androgen deprivation in metastatic hormone-sensitive prostate cancer: A prospective phase 2 single-arm trial.

Jian Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.